Camille L Bedrosian insider trades

Open-market stock purchases and sales by Camille L Bedrosian, Director at Crinetics Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 30, 2018.

Recent trades

DateStockTradeValue
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMLX Amylyx Pharmaceuticals, IncSold$94.2K
Dec 1, 2025AMLX Amylyx Pharmaceuticals, IncSold$94.4K

Companies traded

  • CRNX Crinetics Pharmaceuticals, Inc: other filings, last Jun 18, 2026
  • AMLX Amylyx Pharmaceuticals, Inc: 6 sales, last Mar 5, 2026
  • RYTM Rhythm Pharmaceuticals, Inc: other filings, last Jun 24, 2025
  • RARE Ultragenyx Pharmaceutical Inc: 12 sales, last Mar 1, 2023

Get free alerts when Camille L Bedrosian files a new trade →